Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22

University of Vermont

Status and phase: Completed; Phase 2

Conditions: Opioid-Related Disorders; Cocaine-Related Disorders

Treatments: Drug: Buprenorphine

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000240

R01-06969-22

R01DA006969 (U.S. NIH Grant/Contract)

NIDA-06969-22

Details and patient eligibility

About

The purpose of this study is to test combined buprenorphine and behavioral treatment with and without contingent reinforcement on opioid and cocaine abstinence.

Sex: All

Ages: 23 to 47 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.